307 related articles for article (PubMed ID: 24350418)
1. The factors affecting quality of life in Thai psoriasis patients.
Thakolwiboon S; Upala S; Geeratragool T; Benjatikul N; Uathaya M; Tripipitsiriwat A; Jiranapakul S; Chutinimitkul B; Wongpraparut C; Kulthanan K; Jiamton S
J Med Assoc Thai; 2013 Oct; 96(10):1344-9. PubMed ID: 24350418
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in patients with psoriasis in northern Taiwan.
Lin TY; See LC; Shen YM; Liang CY; Chang HN; Lin YK
Chang Gung Med J; 2011; 34(2):186-96. PubMed ID: 21539761
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
Tang MM; Chang CC; Chan LC; Heng A
Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis affects patient's quality of life more seriously in female than in male in Japan.
Mabuchi T; Yamaoka H; Kojima T; Ikoma N; Akasaka E; Ozawa A
Tokai J Exp Clin Med; 2012 Sep; 37(3):84-8. PubMed ID: 23032250
[TBL] [Abstract][Full Text] [Related]
5. The relationship between quality of life and the severity of psoriasis in Turkey.
Çakmur H; Derviş E
Eur J Dermatol; 2015 Apr; 25(2):169-76. PubMed ID: 25655046
[TBL] [Abstract][Full Text] [Related]
6. Measuring quality of life in patients with psoriasis using the Arabic version for Morocco of the Dermatology Life Quality Index.
Khoudri I; Lamchahab FZ; Ismaili N; Senouci K; Hassam B; Abouqal R
Int J Dermatol; 2013 Jul; 52(7):795-802. PubMed ID: 23488573
[TBL] [Abstract][Full Text] [Related]
7. Dermatology life quality index in Thai patients with systemic sclerosis: a cross-sectional study.
Chularojanamontri L; Sethabutra P; Kulthanan K; Manapajon A
Indian J Dermatol Venereol Leprol; 2011; 77(6):683-7. PubMed ID: 22016275
[TBL] [Abstract][Full Text] [Related]
8. Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study.
Daudén E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Perulero N
Actas Dermosifiliogr; 2013 Oct; 104(8):685-93. PubMed ID: 23958428
[TBL] [Abstract][Full Text] [Related]
9. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
Revicki DA; Willian MK; Menter A; Saurat JH; Harnam N; Kaul M
Dermatology; 2008; 216(3):260-70. PubMed ID: 18187944
[TBL] [Abstract][Full Text] [Related]
10. Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI).
Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):452-6. PubMed ID: 24911993
[TBL] [Abstract][Full Text] [Related]
11. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
[TBL] [Abstract][Full Text] [Related]
12. Psoriasis has a major secondary impact on the lives of family members and partners.
Eghlileb AM; Davies EE; Finlay AY
Br J Dermatol; 2007 Jun; 156(6):1245-50. PubMed ID: 17459044
[TBL] [Abstract][Full Text] [Related]
13. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
[TBL] [Abstract][Full Text] [Related]
14. A descriptive study of psoriasis characteristics, severity and impact among 3,269 patients: results of a Belgian cross sectional study (BELPSO).
Lambert J; Dowlatshahi EA; de la Brassinne M; Nijsten T
Eur J Dermatol; 2012; 22(2):231-7. PubMed ID: 22266338
[TBL] [Abstract][Full Text] [Related]
15. Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients.
Norlin JM; Steen Carlsson K; Persson U; Schmitt-Egenolf M
Br J Dermatol; 2012 Apr; 166(4):797-802. PubMed ID: 22182212
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.
Fernandez-Peñas P; Jones-Caballero M; Espallardo O; García-Díez A
Br J Dermatol; 2012 Apr; 166(4):884-7. PubMed ID: 22229951
[TBL] [Abstract][Full Text] [Related]
17. An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial.
Bostoen J; Bracke S; De Keyser S; Lambert J
Br J Dermatol; 2012 Nov; 167(5):1025-31. PubMed ID: 22709422
[TBL] [Abstract][Full Text] [Related]
18. Quality of life and related factors in a cohort of plaque-type psoriasis patients in La Coruña, Spain.
Fernández-Torres RM; Pita-Fernández S; Fonseca E
Int J Dermatol; 2014 Nov; 53(11):e507-11. PubMed ID: 25266080
[TBL] [Abstract][Full Text] [Related]
19. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
Chaptini C; Quinn S; Marshman G
Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
[TBL] [Abstract][Full Text] [Related]
20. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D;
Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
